Xiaohong Shen

Xiaohong Shen has a diverse work experience starting from the year 1995. xiaohong began their career as an Associate Director at the Production Unit of Ammonia Synthesis Catalysts, Catalyst Plant, NCIC. xiaohong then worked as the Director at the Department of Quality Control, Catalyst Plant, NCIC from July 1998 to November 1999, followed by serving as the Director at the Department of Production Management, Catalyst Plant, NCIC from December 1999 to October 2000.

In 2008, Xiaohong joined Novartis as a Senior Scientist and held this role till June 2013. xiaohong then worked as a Lead Scientist at Purdue Pharma L.P. from June 2013 to April 2015. Xiaohong later joined Ferring Pharmaceuticals as a Project Lead/Senior Scientist from May 2015 to May 2018.

Currently, Xiaohong Shen serves as the Senior Director of Pharmaceutical Development & Technology Transfer at TG Therapeutics, Inc. xiaohong has been working in this position since June 2018.

Xiaohong Shen has studied Pharmaceutical Science at the University of Iowa. The start and end year of the education are not specified.